title: A comparative study of regression of jaundice in patients of malaria and acute viral hepatitis.
abstract: OBJECTIVE
  Jaundice is one of the common manifestations of severe malaria in adults. The purpose of this study is to compare the pattern of clinical and biochemical parameters such as serum bilirubin and liver enzyme levels in patients of malaria with jaundice and acute viral hepatitis.
  
  
  METHODS
  The present study was conducted on 34 patients of malaria with jaundice and 15 patients of acute viral hepatitis. Estimation of serum bilirubin, aspartate amino transferase (AST), alanine amino transferase (ALT) and alkaline phosphatase was done daily using standard procedures in malaria patients and weekly in acute viral hepatitis patients.
  
  
  RESULTS
  Mean level of serum bilirubin on first day in malaria and acute viral hepatitis patients was 7.07 +/- 3.94 and 10.38 +/- 7.87 mg%, whereas on Day 8 it was 1.19 +/- 1.43 and 7.88 +/- 7.02 mg% respectively. Mean level of AST on Day 1 in malaria and acute viral hepatitis patients was 158.47 +/- 120.35 and 1418.6 +/- 834.11 IU/L, whereas on Day 8 it was 41 +/- 28.33 and 775.3 +/- 399.01 IU/L respectively. Mean level of ALT on Day 1 in malaria and acute viral hepatitis patients was 220.14 +/- 145.61 and 1666.67 +/- 1112.77 IU/L, whereas on Day 8 it was 50.85 +/- 37.31 and 823.8 +/- 475.06 IU/L respectively. Mean level of serum alkaline phosphatase on Day 1 in malaria and acute viral hepatitis patients was 394.74 +/- 267.78 and 513.4 +/- 324.7 IU/L, whereas on Day 8 it was 84.76 +/- 68.50 and 369.27 +/- 207.75 IU/L respectively.
  
  
  CONCLUSIONS
  We observed that resolution of jaundice in malaria took 1-2 weeks in contrast 6 to 8 weeks in viral hepatitis. This difference in duration was statistically significant. Thus, jaundice not resolving in 1-2 weeks time in a patient of malaria requires serious consideration for presence of other concomitant diseases including viral hepatitis.
authors.affiliation: Department of Medicine, S.P Medical College, Bikaner, India. drdkkochar@yahoo.com
authors.forename: D K
authors.initials: DK
authors.lastname: Kochar
authors.forename: K
authors.initials: K
authors.lastname: Kaswan
authors.forename: S K
authors.initials: SK
authors.lastname: Kochar
authors.forename: P
authors.initials: P
authors.lastname: Sirohi
authors.forename: M
authors.initials: M
authors.lastname: Pal
authors.forename: A
authors.initials: A
authors.lastname: Kochar
authors.forename: R P
authors.initials: RP
authors.lastname: Agrawal
authors.forename: A
authors.initials: A
authors.lastname: Das
mesh_terms: D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D005260:Female; D006526:Hepatitis C / Q000150:complications*; D006761:Hospitals; D006801:Humans; D007194:India; D007565:Jaundice / Q000097:blood / Q000209:etiology / Q000503:physiopathology*; D008288:Malaria / Q000150:complications*; D008297:Male; D011446:Prospective Studies; D020127:Recovery of Function; D013997:Time Factors
chemical_list: D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D001663:Bilirubin